• Biotin-HPDP for Thiol-Specific Protein Labeling in Redox Bio

  2026-06-10

  Biotin-HPDP offers unmatched precision and reversibility for thiol-specific protein biotinylation, enabling advanced detection of dynamic protein modifications in redox and neurodegeneration research. Its unique chemistry streamlines workflows for S-nitrosylation detection and affinity purification, empowering reproducible, high-sensitivity assays in challenging biological systems.

• Reliable Assays with Dovitinib (TKI-258, CHIR-258): Best Pra

  2026-06-09

  This article delivers an actionable, evidence-based roadmap for leveraging Dovitinib (TKI-258, CHIR-258) (SKU A2168) in cell viability, proliferation, and cytotoxicity workflows. Drawing on peer-reviewed data and real-world lab scenarios, we clarify best practices for RTK inhibition, apoptosis induction, and data interpretation, empowering researchers to overcome reproducibility and reliability challenges.

• Small-Molecule uPAR Inhibition Blocks Breast Cancer Metastas

  2026-06-09

  This study establishes IPR-803 as a potent small-molecule urokinase receptor inhibitor that selectively disrupts the uPAR–uPA interaction driving tumor invasion and metastasis. Through rigorous biochemical, cellular, and in vivo models, the research demonstrates both the mechanistic specificity and translational potential of targeting the uPAR axis in breast cancer.

• Protease Inhibitor Cocktail: Unlocking Plant Protein Stabili

  2026-06-08

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers researchers to preserve plant cell proteins with unmatched fidelity, even in phosphoprotein-rich extracts. Its broad-spectrum, EDTA-free formulation is a game-changer for robust Western blots, kinase assays, and beyond—especially where downstream metal-dependent analyses or immunological readouts require uncompromised integrity.

• Tamsulosin and the Prevention of Postoperative Urinary Reten

  2026-06-08

  This systematic review and meta-analysis provides robust evidence that tamsulosin, a selective α₁A-adrenergic receptor antagonist, significantly lowers the risk of postoperative urinary retention (POUR) without increasing adverse events. The findings refine prophylaxis strategies for POUR and inform translational research on smooth muscle relaxation and GPCR pathway modulation.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Translation

  2026-06-07

  Explore how the JC-1 Mitochondrial Membrane Potential Assay Kit enables advanced mitochondrial membrane potential assays for immunomodulatory and oncology research. This article reveals unique translational applications and mechanistic insights beyond current reviews.

• Air Pollutant-Induced Secretome Changes in Airway Epithelium

  2026-06-06

  This study provides mechanistic insight into how ozone and diesel exhaust particles disrupt human airway epithelial barrier function, focusing on convergent inflammatory signaling and secretome alterations. Findings highlight the value of air–liquid interface models for mimicking real-world exposures and identify shared downstream pathways, such as Wnt signaling, as potential therapeutic targets.

• IWP-2 as a Wnt Production Inhibitor: Advanced Protocols & Us

  2026-06-05

  IWP-2 stands out as a robust tool for dissecting Wnt/β-catenin signaling in cancer and regenerative medicine. This article details experimental workflows, troubleshooting strategies, and practical insights that position IWP-2 as a flexible and high-potency Wnt production inhibitor for advanced research.

• Dissecting Drug-Induced Cell Death: Insights from MEDUSA Scr

  2026-06-05

  The referenced study introduces MEDUSA, an analytic framework separating growth and death rates in functional genomic drug screens. This approach uncovers the genetic dependencies of drug-induced cell death, highlighting a p53-dependent switch in death mechanisms—a finding with practical implications for cancer pharmacology and mechanistic research.

• SAR131675: Precision VEGFR-3 Inhibition for Lymphangiogenesi

  2026-06-04

  This article provides a scenario-driven exploration of SAR131675, a selective and ATP-competitive VEGFR-3 inhibitor (SKU B2301), as a rigorously validated tool for dissecting lymphangiogenesis and angiogenesis in preclinical models. Through evidence-backed Q&A, it addresses common experimental challenges—highlighting SAR131675's specificity, reproducibility, and vendor reliability for advanced vascular research.

• Ranolazine as an Anti-Ischemic Agent: Applied Workflows & Op

  2026-06-04

  Ranolazine excels in cardiac ischemia research by uniquely combining late sodium current inhibition with metabolic modulation, enabling robust study designs for myocardial relaxation and metabolic efficiency. This article delivers advanced workflow strategies, troubleshooting guidance, and translational insights powered by APExBIO's high-purity Ranolazine.

• Carbon-Ion Radiotherapy Drives Ferroptosis via DHODH in Gast

  2026-06-03

  This study demonstrates that carbon-ion radiotherapy (CIRT) suppresses gastric cancer progression by inducing ferroptosis and promoting M1 macrophage polarization through downregulation of DHODH. The findings provide mechanistic insight into how high-LET radiotherapy can reshape tumor biology and immune microenvironment, highlighting new therapeutic opportunities for advanced gastric cancer.

• Mitoxantrone HCl Targets ERα DBD-LBD Interface to Combat Res

  2026-06-03

  Wang et al. reveal that mitoxantrone, a DNA topoisomerase II inhibitor, disrupts estrogen receptor alpha (ERα) function by binding a newly identified DBD-LBD interface, leading to proteasomal degradation of both wild-type and therapy-resistant ERα mutants. This mechanism offers an alternative therapeutic strategy for overcoming endocrine resistance in breast cancer models.

• H-Aggregated NIR-II IR-1061 Liposomes Enable Synergistic Can

  2026-06-02

  Yu et al. present a targeted lipid nanosystem using H-aggregated IR-1061 to enable simultaneous NIR-II fluorescence imaging and photothermal therapy (PTT) for cancer. This approach enhances tumor targeting and therapeutic performance, providing new insight into organic fluorescent dye design for deep tissue molecular imaging applications.

• Indomethacin in Advanced Inflammation and Membrane Research

  2026-06-02

  Explore the multifaceted mechanisms of indomethacin, a nonsteroidal anti-inflammatory drug, in inflammation research and membrane signaling. This in-depth analysis reveals new insights and practical protocols for advanced biomedical investigations.

449 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page